fda compounding semaglutide crackdown september 2025 July 29, 2024: issued new alert about compounded – Partnership for Safe Medicines New project announcement: HHS‑OIG is

GLP-1 medications are a type of drug traditionally used to treat type 2 diabetes

Emerging data also suggest that GLP-1 drugs may reprogram certain cells in different organs, he said

This can potentially lead to a bunch of issues like headaches, fatigue, and nutrient deficiencies

For pharma marketers, this represents a dramatic change

Acute treatment of diet-induced obese mice with labelled semaglutide has been shown to allow the drug to access circumventricular organs that lack a substantial blood brain barrier, including the area postrema (AP), median eminence (ME), vascular organ of the lamina terminalis (OV), and subfornical organ (SFO) (33)

In terms of efficacy, both ingredients have been shown to be effective in reducing the appearance of hyperpigmentation in various studies